EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells

Yasuyuki Akasaka, Shun Hasei, Yukino Ohata, Machi Kanna, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Akifumi Kushiyama iD, Hiraku Ono, Akio Matsubara, Nobuyuki Hinata iD, Tomoichiro Asano und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242116011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yasuyuki Akasaka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Citrus hassaku extract reportedly activates AMPK. Because this extract contains an abundance of auraptene, we investigated whether pure auraptene activates AMPK and inhibits proliferation using prostate cancer cell lines. Indeed, auraptene inhibited the proliferation and migration of LNCaP cells and induced phosphorylation of AMPK or its downstream ACC in LNCaP, PC3, and HEK-293 cells, but not in DU145 cells not expressing LKB1. In addition, the mTOR-S6K pathway, located downstream from activated AMPK, was also markedly suppressed by auraptene treatment. Importantly, it was shown that auraptene reduced androgen receptor (AR) and prostate-specific antigen (PSA) expressions at both the protein and the mRNA level. This auraptene-induced downregulation of PSA was partially but significantly reversed by treatment with AMPK siRNA or the AMPK inhibitor compound C, suggesting AMPK activation to, at least partially, be causative. Finally, in DU145 cells lacking the LKB1 gene, exogenously induced LKB1 expression restored AMPK phosphorylation by auraptene, indicating the essential role of LKB1. In summary, auraptene is a potent AMPK activator that acts by elevating the AMP/ATP ratio, thereby potentially suppressing prostate cancer progression, via at least three molecular mechanisms, including suppression of the mTOR-S6K pathway, reduced lipid synthesis, and AR downregulation caused by AMPK activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesProstatic NeoplasmsMaleHumansPhosphorylationProtein Serine-Threonine KinasesProstate-Specific AntigenReceptors, AndrogenProstateHEK293 CellsAMP-Activated Protein Kinase KinasesTOR Serine-Threonine KinasesCell ProliferationCell Line, TumorCoumarins

Stichwörter der Autor:innen

AMPKLKB1androgen receptoraurapteneprostate cancerprostate-specific antigen

Substanzen

AMP-Activated Protein KinasesProtein Serine-Threonine KinasesProstate-Specific AntigenReceptors, AndrogenAMP-Activated Protein Kinase KinasesTOR Serine-Threonine KinasesauraptenCoumarins

Autor:innen und Institutionen

  • Department of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
  • Department of Bioregulatory Sciences, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan.
  • Division of Diabetes and Metabolic Diseases, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  • Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose 204-8588, Japan.
  • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Department of Urology, JA Hiroshima General Hospital, Hatsukaichi 738-8503, Japan.

ORCID-Profile: Akifumi Kushiyama, Nobuyuki Hinata

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Akasaka, Y., Hasei, S., Ohata, Y., Kanna, M., Nakatsu, Y., Sakoda, H., Fujishiro, M., Kushiyama, A., Ono, H., Matsubara, A., Hinata, N., Asano, T., & Yamamotoya, T. (2023). Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242116011

Vancouver

Akasaka Y, Hasei S, Ohata Y, Kanna M, Nakatsu Y, Sakoda H, et al. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242116011

BibTeX
@article{Akasaka2023,
  author = {Akasaka, Yasuyuki and Hasei, Shun and Ohata, Yukino and Kanna, Machi and Nakatsu, Yusuke and Sakoda, Hideyuki and Fujishiro, Midori and Kushiyama, Akifumi and Ono, Hiraku and Matsubara, Akio and Hinata, Nobuyuki and Asano, Tomoichiro and Yamamotoya, Takeshi},
  title = {Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242116011}
}
Kostenlos starten →